Algert Global’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $722K | Sell |
13,055
-5,610
| -30% | -$310K | 0.02% | 867 |
|
|
2025
Q1 | $903K | Buy |
18,665
+945
| +5% | +$45.7K | 0.02% | 788 |
|
|
2024
Q4 | $684K | Sell |
17,720
-97,959
| -85% | -$3.78M | 0.02% | 863 |
|
|
2024
Q3 | $5.21M | Sell |
115,679
-36,400
| -24% | -$1.64M | 0.14% | 238 |
|
|
2024
Q2 | $5.27M | Buy |
152,079
+4,236
| +3% | +$147K | 0.18% | 165 |
|
|
2024
Q1 | $4.28M | Buy |
147,843
+72,083
| +95% | +$2.09M | 0.17% | 201 |
|
|
2023
Q4 | $1.74M | Buy |
75,760
+2,930
| +4% | +$67.2K | 0.07% | 459 |
|
|
2023
Q3 | $1.22M | Buy |
72,830
+45,600
| +167% | +$761K | 0.06% | 523 |
|
|
2023
Q2 | $752K | Buy |
27,230
+6,170
| +29% | +$170K | 0.03% | 720 |
|
|
2023
Q1 | $484K | Sell |
21,060
-63,112
| -75% | -$1.45M | 0.02% | 829 |
|
|
2022
Q4 | $918K | Buy |
84,172
+13,240
| +19% | +$144K | 0.05% | 605 |
|
|
2022
Q3 | $598K | Sell |
70,932
-17,165
| -19% | -$145K | 0.04% | 747 |
|
|
2022
Q2 | $697K | Buy |
88,097
+63,780
| +262% | +$505K | 0.05% | 624 |
|
|
2022
Q1 | $576K | Buy |
+24,317
| New | +$576K | 0.04% | 757 |
|
|
2019
Q3 | – | Sell |
-15,517
| Closed | -$188K | – | 423 |
|
|
2019
Q2 | $188K | Buy |
15,517
+5,030
| +48% | +$60.9K | 0.07% | 280 |
|
|
2019
Q1 | $132K | Sell |
10,487
-3,554
| -25% | -$44.7K | 0.08% | 269 |
|
|
2018
Q4 | $94K | Sell |
14,041
-30,436
| -68% | -$204K | 0.03% | 357 |
|
|
2018
Q3 | $458K | Sell |
44,477
-7,430
| -14% | -$76.5K | 0.1% | 259 |
|
|
2018
Q2 | $349K | Buy |
+51,907
| New | +$349K | 0.07% | 273 |
|